Alzheimer’s Drug Discovery Foundation Chief Executive Officer Mark Roithmayr Announces Retirement in 2025
NEW YORK, April 24, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that Mark Roithmayr will retire from his role as Chief Executive Officer effective December 31,